{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:58:30Z","timestamp":1790639910397,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04794-2","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T10:52:16Z","timestamp":1790592736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The cardiometabolic significance of post-dexamethasone cortisol levels below the MACS threshold in adrenal incidentaloma"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2988-7488","authenticated-orcid":false,"given":"Elif Seray","family":"Korkmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5902-3042","authenticated-orcid":false,"given":"Birsen","family":"\u00d6zt\u00fcrk G\u00f6k\u00e7e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8286-5256","authenticated-orcid":false,"given":"Medine Nur","family":"Kebap\u00e7\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"4794_CR1","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMcp065470","volume":"356","author":"WF Young Jr","year":"2007","unstructured":"W.F. Jr. Young, Clinical practice. The incidentally discovered adrenal mass. N Engl. J. Med. 356, 601\u2013610 (2007). https:\/\/doi.org\/10.1056\/NEJMcp065470","journal-title":"N Engl. J. Med."},{"key":"4794_CR2","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"M. Fassnacht, W. Arlt, I. Bancos, H. Dralle, J. Newell-Price, A. Sahdev et al., Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline. Eur. J. Endocrinol. Eur. J. Endocrinol. 175, G1\u2013G34 (2016). https:\/\/doi.org\/10.1530\/EJE-16-0467","journal-title":"Eur. J. Endocrinol. Eur. J. Endocrinol."},{"issue":"11","key":"4794_CR3","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","volume":"106","author":"I Bancos","year":"2021","unstructured":"I. Bancos, A. Prete, Approach to the Patient With Adrenal Incidentaloma. J. Clin. Endocrinol. Metab. 106(11), 3331\u20133353 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgab512","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4794_CR4","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12020-022-03228-z","volume":"79","author":"M Araujo-Castro","year":"2023","unstructured":"M. Araujo-Castro, P. Parra-Ram\u00edrez, P. Mart\u00edn-Rojas-Marcos, R. Garc\u00eda-Centeno, P. Gracia-Gimeno, M. Tom\u00e9-Fern\u00e1ndez-Ladreda et al., Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test\u2009>\u20090.9 \u00b5g\/dL have a higher prevalence of cardiovascular disease than those with values\u2009\u2264\u20090.9 \u00b5g\/dL. Endocrine. 79, 384\u2013391 (2023). https:\/\/doi.org\/10.1007\/s12020-022-03228-z","journal-title":"Endocrine"},{"key":"4794_CR5","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1007\/s40618-025-02679-1","volume":"48","author":"V Favero","year":"2025","unstructured":"V. Favero, C. Eller-Vainicher, V. Morelli, A. Scillitani, I. Chiodini, Lowering the dexamethasone suppression test cut-off: is it time yet? J. Endocrinol. Invest. 48, 2831\u20132843 (2025). https:\/\/doi.org\/10.1007\/s40618-025-02679-1","journal-title":"J. Endocrinol. Invest."},{"issue":"9","key":"4794_CR6","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.3390\/biomedicines13092169","volume":"13","author":"AI Trandafir","year":"2025","unstructured":"A.I. Trandafir, M. Carsote, Dexamethasone suppression test in adrenal incidentaloma with and without mild autonomous cortisol secretion: a spectrum of cortisol thresholds and additional analyses (an updated analysis). Biomedicines. 13(9), 2169 (2025). https:\/\/doi.org\/10.3390\/biomedicines13092169","journal-title":"Biomedicines"},{"key":"4794_CR7","doi-asserted-by":"publisher","first-page":"101494","DOI":"10.1016\/j.beem.2021.101494","volume":"35","author":"C Aresta","year":"2021","unstructured":"C. Aresta, V. Favero, V. Morelli, C. Eller-Vainicher, G. Reimondo, A. Pia et al., Cardiovascular complications of mild autonomous cortisol secretion. Best Pract. Res. Clin. Endocrinol. Metab. 35, 101494 (2021). https:\/\/doi.org\/10.1016\/j.beem.2021.101494","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"3","key":"4794_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.suc.2004.01.001","volume":"84","author":"RS Sippel","year":"2004","unstructured":"R.S. Sippel, H. Chen, Subclinical Cushing\u2019s syndrome in adrenal incidentalomas. Surg. Clin. North. Am. 84(3), 875\u2013885 (2004). https:\/\/doi.org\/10.1016\/j.suc.2004.01.001","journal-title":"Surg. Clin. North. Am."},{"issue":"2","key":"4794_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ecl.2005.01.008","volume":"34","author":"M Terzolo","year":"2005","unstructured":"M. Terzolo, S. Bovio, G. Reimondo, A. Pia, G. Osella, G. Borretta et al., Subclinical Cushing\u2019s syndrome in adrenal incidentalomas. Endocrinol. Metab. Clin. North. Am. 34(2), 423\u2013439 (2005). https:\/\/doi.org\/10.1016\/j.ecl.2005.01.008","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"4794_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/0002-9343(84)90952-5","volume":"76","author":"WP Castelli","year":"1984","unstructured":"W.P. Castelli, Epidemiology of coronary heart disease: the Framingham Study. Am. J. Med. 76, 4\u201312 (1984). https:\/\/doi.org\/10.1016\/0002-9343(84)90952-5","journal-title":"Am. J. Med."},{"key":"4794_CR11","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1373\/clinchem.2004.033175","volume":"50","author":"M Dobiasova","year":"2004","unstructured":"M. Dobiasova, Atherogenic index of plasma [log(triglycerides\/HDL-cholesterol)]: theoretical and practical implications. Clin. Chem. 50, 1113\u20131115 (2004). https:\/\/doi.org\/10.1373\/clinchem.2004.033175","journal-title":"Clin. Chem."},{"key":"4794_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"L.E. Simental-Mend\u00eda, M. Rodr\u00edguez-Mor\u00e1n, F. Guerrero-Romero, The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance. Metab. Syndr. Relat. Disord. 6, 299\u2013304 (2008). https:\/\/doi.org\/10.1089\/met.2008.0034","journal-title":"Metab. Syndr. Relat. Disord"},{"key":"4794_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12944-025-02821-1","volume":"24","author":"L Cui","year":"2025","unstructured":"L. Cui, F. Zhou, Y. Chen, R. Liu, Y. Xing, The lipid ratio Castelli\u2019s risk index II is a novel biomarker for intraplaque neovascularization in patients with carotid stenosis. Lipids Health Dis. 24, 22 (2025). https:\/\/doi.org\/10.1186\/s12944-025-02821-1","journal-title":"Lipids Health Dis."},{"issue":"12","key":"4794_CR14","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1210\/jc.2014-3007","volume":"99","author":"M Debono","year":"2014","unstructured":"M. Debono, M. Bradburn, M. Bull, B. Harrison, R.J. Ross, J. Newell-Price et al., Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas. J. Clin. Endocrinol. Metab. 99(12), 4462\u20134470 (2014). https:\/\/doi.org\/10.1210\/jc.2014-3007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4794_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","volume":"2","author":"G Di Dalmazi","year":"2014","unstructured":"Di G. Dalmazi, V. Vicennati, S. Garelli, E. Casadio, E. Rinaldi, E. Giampalma et al., Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol. 2(5), 396\u2013405 (2014). https:\/\/doi.org\/10.1016\/S2213-8587(13)70211-0","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"4794_CR16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s12020-013-0117-1","volume":"46","author":"V Morelli","year":"2014","unstructured":"V. Morelli, G. Reimondo, R. Giordano, S. Della Casa, C. Policola, S. Palmieri et al., Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects. Endocrine. 46(3), 681\u2013688 (2014). https:\/\/doi.org\/10.1007\/s12020-013-0117-1","journal-title":"Endocrine"},{"issue":"4","key":"4794_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1530\/EJE-11-1039","volume":"166","author":"C Eller-Vainicher","year":"2012","unstructured":"C. Eller-Vainicher, V. Morelli, A.S. Salcuni, M. Torlontano, F. Coletti, L. Iorio et al., Cardiometabolic risk in patients with mild cortisol excess. Eur. J. Endocrinol. 166(4), 669\u2013677 (2012). https:\/\/doi.org\/10.1530\/EJE-11-1039","journal-title":"Eur. J. Endocrinol."},{"key":"4794_CR18","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1172\/JCI116469","volume":"91","author":"S Dinneen","year":"1993","unstructured":"S. Dinneen, A. Alzaid, J.M. Miles, R.A. Rizza, Effects of cortisol on insulin sensitivity in humans. J. Clin. Invest. 91, 1910\u20131917 (1993). https:\/\/doi.org\/10.1172\/JCI116469","journal-title":"J. Clin. Invest."},{"issue":"10","key":"4794_CR19","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1210\/jc.2012-1678","volume":"97","author":"G Di Dalmazi","year":"2012","unstructured":"Di G. Dalmazi, V. Vicennati, E. Rinaldi, A.M. Morselli-Labate, E. Giampalma, C. Mosconi et al., Subclinical hypercortisolism: prevalence and cardiovascular risk in patients with adrenal incidentalomas. J. Clin. Endocrinol. Metab. 97(10), 3531\u20133539 (2012). https:\/\/doi.org\/10.1210\/jc.2012-1678","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"4794_CR20","first-page":"1761","volume":"47","author":"M Dobiasova","year":"2001","unstructured":"M. Dobiasova, J. Frohlich, The plasma parameter log(TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma. Clin. Chem. 47(10), 1761\u20131767 (2001)","journal-title":"Clin. Chem."},{"issue":"1","key":"4794_CR21","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad045","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"M. Fassnacht, O.M. Dekkers, T. Else, E. Baudin, C.M. Berr, F. Beuschlein et al., European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 189(1), G1\u2013G42 (2023). https:\/\/doi.org\/10.1093\/ejendo\/lvad045","journal-title":"Eur. J. Endocrinol."},{"key":"4794_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12902-025-02090-0","volume":"25","author":"S Yener","year":"2025","unstructured":"S. Yener, G. Tuna, H. \u015eahin, S.C. Ad\u0131yaman, B.O. Saydam, M. Bar\u0131\u015f et al., Estimation of cortisol exposure in patients with adrenal incidentalomas. BMC Endocr. Disord. 25, 266 (2025). https:\/\/doi.org\/10.1186\/s12902-025-02090-0","journal-title":"BMC Endocr. Disord"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04794-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04794-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04794-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:03:18Z","timestamp":1790636598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04794-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4794"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04794-2","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"25 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Eski\u015fehir Osmangazi University Non-Interventional Clinical Research Ethics Committee (Approval No. 14, dated November 28, 2023). All patient data were analyzed in accordance with institutional confidentiality regulations.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"319"}}